Improvement of dysphagia in a child affected by Pompe disease treated with enzyme replacement therapy

AIM: Dysphagia is a known complication in Pompe Disease (PD), a severe metabolic myopathy due to alpha-glucosidase deficiency. Enzyme replacement therapy (ERT) with alglucosidase alfa is the only approved therapy for PD. Presently no data are available on the effects of ERT on dysphagia in PD patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Fecarotta, Simona, Ascione, Serena, Montefusco, Giuseppe, Della Casa, Roberto, Villari, Paola, Romano, Alfonso, Del Giudice, Ennio, Andria, Generoso, Parenti, Giancarlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667015/
https://www.ncbi.nlm.nih.gov/pubmed/23668440
http://dx.doi.org/10.1186/1824-7288-39-30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667015/
https://www.ncbi.nlm.nih.gov/pubmed/23668440
http://dx.doi.org/10.1186/1824-7288-39-30

Ejemplares similares